Serum Institute of India CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic in the country.
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country, said Dr NK Arora, chairman of the Covid working group, National Technical Adviso
As per the complaint, Satish Deshpande, one of the directors at the SII had received a message on WhatsApp from a person posing as SII CEO Adar Poonawalla and was asked to send money into seven different accounts in September 2022. Believing the message was from Poonawala, Deshpande transfer
New Delhi [India], October 21 (ANI): The production of India's first indigenously developed quadrivalent Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer, by the Serum Institute of India will start in the first quarter of 2023 which got delayed due to C
Pune (Maharashtra) [India], October 20 (ANI): Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said that the medical firm stopped the production of the Covishield vaccine since December 2021.
New Delhi [India], September 29 (ANI): The Drugs controller general of India (DCGI) allowed the export of approximately 2 lakh vaccine doses of Malaria which is produced in India, said sources on Thursday.
Pune (Maharashtra) [India], September 11 (ANI): An FIR was launched against some unidentified persons for cheating the Serum Institute of India for more than Rs. 1 crore, said the officials on Sunday.
Mumbai (Maharashtra) [India] September 3 (ANI): The Bombay High Court issued notices to the Government of India, Serum Institute of India (SII), Microsoft founder Bill Gates, All India Institute of Medical Science Director, DCGI chief and others after a petition was filed by father of a l
New Delhi [India], September 1 (ANI: India's first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said Serum Institute of India (SII) CEO Adar Poonawala on Thursday.
New Delhi [India], August 31 (ANI): The Serum Institute of India (SII) and the Department of Biotechnology(DBT) are set to launch India's first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against Cervical Cancer on September 1, official sources told ANI.
Pune (Maharashtra) [India], August 17 (ANI): Highlighting 75 years of the US-India bilateral relationship and their cooperation on health issues, a US delegation visited the Serum Institute of India (SII) in Pune today and noted the critical role played by US-India cooperation in addressing